Phase I multicenter, open-label, dose escalation study of T-1201, a small molecule drug conjugate, to assess safety, pharmacokinetics, and antitumor activity in advanced solid tumors.

Authors: Hui-Ching Wang, Yu-Min Yeh, Tsung-Jang Yeh, Jui-Hung Tsai, Yuhching Gau, Li-Tzong Chen, Hsiao-Fang Li

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps3162

Source: Full article

---

Abstract

TPS3162